This is consistent with previous studies showing that CD44v3+/CD24– and CD44v3+/ALDH1+ cells possess CSCs properties in human oral squamous cell carcinoma [18] and HNSCC [19], respectively. This evidence concerns the gene ALDH1A1 and head and neck squamous cell carcinoma.